Page 7 - Authorized Use News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pfizer Inc : Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 Vaccine

First results from any randomized, controlled COVID-19 vaccine booster trial demonstrate a relative vaccine efficacy of 95.6% against disease during a period when Delta was the prevalent strain

United statesUnited kingdomSylke maasAlbert bourlaUgur sahinFosun pharmaCenters for diseaseDrug administrationBayer animal healthExchange commissionPfizer incEuropean unionEuropean medicines agencyRoche groupChief executive officerMarketing authorization holder

FDA Accepts REGEN-COV® (casirivimab and imdevimab) for Priority Review for Treatment and Prophylaxis of COVID-19

/PRNewswire/ Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for priority.

United statesUnited kingdomSouth africaSeptember regeneronGeorged yancopoulosTammy allenRegeneron velocimmuneVesna tosicHuman service office of theRegeneron velocimmune technologyTeva pharmaceutical industries ltdDepartment of healthEuropean unionPharmaceuticals incCenters for diseaseRegeneron pharmaceuticals inc

New REGEN-COV™ (casirivimab and imdevimab) Data Show Supportive Results in Patients Hospitalized with COVID-19

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesUnited kingdomSouth africaEleftherios mylonakisGeorged yancopoulosTammy allenRegeneron velocimmuneVesna tosicHuman service office of theRegeneron velocimmune technologyTeva pharmaceutical industries ltdDepartment of healthEuropean unionCenters for diseaseRegeneron pharmaceuticals incBiomedical advanced research

Positive Top-line Results of Pfizer s Phase 3 Study Exploring Coadministration of Prevnar 20 With Seasonal Flu Vaccine in Older Adults Released

Positive Top-line Results of Pfizer s Phase 3 Study Exploring Coadministration of Prevnar 20 With Seasonal Flu Vaccine in Older Adults Released
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.

United statesLuis jodarBryan dunnKathrinu jansenSteve danehyCenters for diseaseHead of vaccine research developmentDrug administrationExchange commissionPfizer incEuropean medicines agencyCommittee for medicinal products human useConjugate vaccineFluad quadrivalentSenior vice presidentVaccine research

New England Journal of Medicine Publishes Positive Phase 3 Trial Results for REGEN-COV™ (casirivimab and imdevimab) to Treat COVID-19

New England Journal of Medicine Publishes Positive Phase 3 Trial Results for REGEN-COV™ (casirivimab and imdevimab) to Treat COVID-19
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSouth africaGeorged yancopoulosTammy allenRegeneron velocimmuneVesna tosicHuman service office of theRegeneron velocimmune technologyAmerican thoracic society international conferenceTeva pharmaceutical industries ltdDepartment of healthEuropean unionPharmaceuticals incCenters for diseaseRegeneron pharmaceuticals inc